Compounds > dimercaprol

dimercaprol and paroxetine

dimercaprol has been researched along with paroxetine in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (33.33)	29.6817
2010's	4 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
García-Mera, X; González-Díaz, H; Prado-Prado, FJ	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Ekins, S; Williams, AJ; Xu, JJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Cahill, CM; Gullans, SR; Payton, S; Randall, JD; Rogers, JT	1
Cuny, GD; Morse, LJ; Payton, SM; Rogers, JT	1

Reviews

1 review(s) available for dimercaprol and paroxetine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

5 other study(ies) available for dimercaprol and paroxetine

Article	Year
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6 Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics	2010
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
Drug discovery targeted to the Alzheimer's APP mRNA 5'-untranslated region: the action of paroxetine and dimercaptopropanol. Journal of molecular neuroscience : MN, 2003, Volume: 20, Issue:3 Topics: 5' Untranslated Regions; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Anti-Bacterial Agents; Azithromycin; Cell Line, Tumor; Chelating Agents; Dimercaprol; Drug Evaluation, Preclinical; Genes, Reporter; Humans; Luciferases; Paroxetine; Protein Synthesis Inhibitors; RNA, Messenger; Selective Serotonin Reuptake Inhibitors	2003
FDA-preapproved drugs targeted to the translational regulation and processing of the amyloid precursor protein. Journal of molecular neuroscience : MN, 2004, Volume: 24, Issue:1 Topics: 5' Untranslated Regions; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Cell Line, Tumor; Chelating Agents; Dimercaprol; Dose-Response Relationship, Drug; Down-Regulation; Drug Evaluation, Preclinical; Epithelial Cells; Humans; Iron; Neuroprotective Agents; Organometallic Compounds; Paroxetine; Protein Biosynthesis; Protein Processing, Post-Translational; Protein Synthesis Inhibitors; Receptors, Transferrin; RNA, Messenger	2004